摘要
18F-FDGPET显像在心脏肿瘤及炎性病变方面应用越来越广泛。在纵隔病变、感染性心内膜炎及冠状动脉斑块显像中，要求尽量降低心肌的生理性摄取，以减少其对病灶的干扰。目前尚缺少抑制心肌摄取FDG的统一标准，笔者综述了通过调整饮食、血糖及使用药物降低心肌生理性摄取18F—FDG的研究进展。
18F-FDG PET has been widely used in myocardial oncology and inflammatory imaging.Suppression of physiological uptake in heart is required for accurate diagnosis of some thoracic diseases, cardiac inflammatory diseases and coronary atherosclerosis. There is no unified criteria to reduce myocardial 18F-FDG uptake. This review summarizes the research progress of inhibiting physiological myocardial 18F-FDG uptake by controlling diet, mediating blood glucose and applying drugs.
出处
《中华核医学与分子影像杂志》
北大核心
2017年第5期305-307,共3页
Chinese Journal of Nuclear Medicine and Molecular Imaging
基金
国家自然科学基金（81401443）
